Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
PETALING JAYA: Vertice Bhd and Consortium Zenith Construction Sdn Bhd have mutually terminated the contract for the construction works for Package 2 of the Penang Mega Infrastructure project worth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback